Finding Hope   Leave a comment

In a recent press release, Rituximab has been shown to reduce the ability for follicular NHL to return after successful chemotherapy.  Hopefully drugs like this can be made to target all forms of NHL from returning.  Who would ever want to have it twice?

According to Professor Peter Littlejohns, Clinical and Public Health Director at NICE, “A maintenance treatment is used to stop a cancer from returning following initial chemotherapy. For follicular non-Hodgkin’s lymphoma, no such maintenance treatment has so far been available and therefore rituximab could be a valuable treatment option for patients with this type of cancer.”

There is another drug called Blinatumomab made by Micromet that I am going to research which targets multiple forms of NHL, helping one to recover from a relapse.  I will try to post on this tomorrow but have too many projects to grade tonight.


Posted December 8, 2010 by lymphomactivist in Uncategorized

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: